Nasal Bacteria Pump Out a Potential New Antibiotic That Kills MRSA

Post by taneq » Thu, Jul 28, 2016, 7:06 AM UTC

Benjamin_Dobell wrote: post #9

JumpCrisscross wrote: post #7

Earlier quoted context omitted.

You have to choose a system. If we don't want naturally-occurring compounds patented, but we want them researched for potential drug use, we need more public funding. Otherwise, we have to offer researchers and drug manufacturers an incentive to take risks with exploring these compounds. Barring lugdunin from being patented while providing no public funding would incentivise this group to withhold publication until t…

At least if they'd kept their findings secret, researchers could independently be researching the same thing. Now independent researchers won't want to touch lugdunin because they'll need to license the patent, however they won't know whether licensing the patent is worthwhile until they do their research. This will prevent further research, not encourage it.

Post by Scarblac » Thu, Jul 28, 2016, 7:27 AM UTC

JumpCrisscross wrote: post #7

Benjamin_Dobell wrote: post #4

Awesome research. But... > The researchers then checked snot from hospitalized patients. Of 187 samples, all but one were colonized by either S. aureus or S. lugdunensis > S. lugdunensis, was killing S. aureus. Its weapon of choice? A small compound dubbed lugdunin > The German researchers who performed the study have filed a patent for lugdunin Are we really allowing people to patent naturally occurring biological c…

You have to choose a system. If we don't want naturally-occurring compounds patented, but we want them researched for potential drug use, we need more public funding. Otherwise, we have to offer researchers and drug manufacturers an incentive to take risks with exploring these compounds. Barring lugdunin from being patented while providing no public funding would incentivise this group to withhold publication until t…

Post by fauigerzigerk » Thu, Jul 28, 2016, 7:35 AM UTC

Scarblac wrote: post #33

JumpCrisscross wrote: post #7

Earlier quoted context omitted.

You have to choose a system. If we don't want naturally-occurring compounds patented, but we want them researched for potential drug use, we need more public funding. Otherwise, we have to offer researchers and drug manufacturers an incentive to take risks with exploring these compounds. Barring lugdunin from being patented while providing no public funding would incentivise this group to withhold publication until t…

These are German researchers at a German university. Aren't they already publicly funded? (honest question, I don't know).

Post by JumpCrisscross » Thu, Jul 28, 2016, 7:45 AM UTC

lifeisstillgood wrote: post #17

Now we need a globally agreed system of anti-biotic triage - you can have anti-biotics, but only administered in hospital, signed off by two doctors and with these life threatening conditions. Treat them with care this time round

Post by arviewer » Thu, Jul 28, 2016, 7:48 AM UTC

mvanvoorden wrote: post #36

Partly relevant: a few months ago they discovered bacteria in beards that also kill MRSA: http://www.independent.co.uk/news/science/beards-good-for-he...